Venture&Growth
Location
Wayne (PA), USA
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
US-based MedTech company developing a novel venous stent.
Vesper Medical is a medical device company dedicated to the development of a novel venous stent for the treatment of a variety of venous diseases. The company had achieved CE Mark and has initiated the VIVID trial in the US for FDA approval. Vesper was founded in 2016 as a spin-out of Intact Vascular.
In 2022, Royal Philips acquired 100% of the Vesper shares, providing Gilde with an attractive return within a three-year holding period.
More Vesper Medical news
Vesper Medical Announces First Enrollment in the VIVID Trial
Gilde Healthcare co-leads $37M financing of Vesper Medical to complete development of its Duo Venous Stent System
Venture&Growth
ADCendo
Danish Therapeutics company focused on antibody-drug conjugates (ADCs) for the treatment of cancers.
Venture&Growth
Nyxoah
Belgian Healthtech company focused on the treatment of sleep apnea.
Venture&Growth
Inari Medical
US MedTech company focused on removal of blood clots to treat pulmonary embolism or deep vein thrombosis.
